BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 17343955)

  • 1. Dissecting the functional domain requirements of cortactin in invadopodia formation.
    Webb BA; Jia L; Eves R; Mak AS
    Eur J Cell Biol; 2007 Apr; 86(4):189-206. PubMed ID: 17343955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation.
    Ayala I; Baldassarre M; Giacchetti G; Caldieri G; Tetè S; Luini A; Buccione R
    J Cell Sci; 2008 Feb; 121(Pt 3):369-78. PubMed ID: 18198194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function.
    Artym VV; Zhang Y; Seillier-Moiseiwitsch F; Yamada KM; Mueller SC
    Cancer Res; 2006 Mar; 66(6):3034-43. PubMed ID: 16540652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
    Clark ES; Whigham AS; Yarbrough WG; Weaver AM
    Cancer Res; 2007 May; 67(9):4227-35. PubMed ID: 17483334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts.
    Mizutani K; Miki H; He H; Maruta H; Takenawa T
    Cancer Res; 2002 Feb; 62(3):669-74. PubMed ID: 11830518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of extracellular matrix-digesting invadopodia by primary aortic smooth muscle cells.
    Furmaniak-Kazmierczak E; Crawley SW; Carter RL; Maurice DH; Côté GP
    Circ Res; 2007 May; 100(9):1328-36. PubMed ID: 17446433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortactin involvement in the keratinocyte growth factor and fibroblast growth factor 10 promotion of migration and cortical actin assembly in human keratinocytes.
    Ceccarelli S; Cardinali G; Aspite N; Picardo M; Marchese C; Torrisi MR; Mancini P
    Exp Cell Res; 2007 May; 313(9):1758-77. PubMed ID: 17449030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells.
    Bowden ET; Onikoyi E; Slack R; Myoui A; Yoneda T; Yamada KM; Mueller SC
    Exp Cell Res; 2006 May; 312(8):1240-53. PubMed ID: 16442522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion.
    Mader CC; Oser M; Magalhaes MA; Bravo-Cordero JJ; Condeelis J; Koleske AJ; Gil-Henn H
    Cancer Res; 2011 Mar; 71(5):1730-41. PubMed ID: 21257711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation.
    Bowden ET; Barth M; Thomas D; Glazer RI; Mueller SC
    Oncogene; 1999 Aug; 18(31):4440-9. PubMed ID: 10442635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
    Yamaguchi H; Takeo Y; Yoshida S; Kouchi Z; Nakamura Y; Fukami K
    Cancer Res; 2009 Nov; 69(22):8594-602. PubMed ID: 19887621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortactin is essential for F-actin assembly in enteropathogenic Escherichia coli (EPEC)- and enterohaemorrhagic E. coli (EHEC)-induced pedestals and the alpha-helical region is involved in the localization of cortactin to bacterial attachment sites.
    Cantarelli VV; Kodama T; Nijstad N; Abolghait SK; Iida T; Honda T
    Cell Microbiol; 2006 May; 8(5):769-80. PubMed ID: 16611226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells.
    Lizárraga F; Poincloux R; Romao M; Montagnac G; Le Dez G; Bonne I; Rigaill G; Raposo G; Chavrier P
    Cancer Res; 2009 Apr; 69(7):2792-800. PubMed ID: 19276357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for cortactin in Listeria monocytogenes invasion of NIH 3T3 cells, but not in its intracellular motility.
    Barroso C; Rodenbusch SE; Welch MD; Drubin DG
    Cell Motil Cytoskeleton; 2006 Apr; 63(4):231-43. PubMed ID: 16489553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia.
    Oser M; Mader CC; Gil-Henn H; Magalhaes M; Bravo-Cordero JJ; Koleske AJ; Condeelis J
    J Cell Sci; 2010 Nov; 123(Pt 21):3662-73. PubMed ID: 20971703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MMP9 on invadopodia formation in cells from adenoid cystic carcinoma. Study by laser scanning confocal microscopy.
    Nascimento CF; Gama-De-Souza LN; Freitas VM; Jaeger RG
    Microsc Res Tech; 2010 Feb; 73(2):99-108. PubMed ID: 19658178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell cortactin phosphorylation by Src contributes to polymorphonuclear leukocyte transmigration in vitro.
    Yang L; Kowalski JR; Zhan X; Thomas SM; Luscinskas FW
    Circ Res; 2006 Feb; 98(3):394-402. PubMed ID: 16385081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratifying fascin and cortactin function in invadopodium formation using inhibitory nanobodies and targeted subcellular delocalization.
    Van Audenhove I; Boucherie C; Pieters L; Zwaenepoel O; Vanloo B; Martens E; Verbrugge C; Hassanzadeh-Ghassabeh G; Vandekerckhove J; Cornelissen M; De Ganck A; Gettemans J
    FASEB J; 2014 Apr; 28(4):1805-18. PubMed ID: 24414419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of invadopodia in a complex 3D environment.
    Tolde O; Rösel D; Veselý P; Folk P; Brábek J
    Eur J Cell Biol; 2010 Sep; 89(9):674-80. PubMed ID: 20537759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invadopodia: at the cutting edge of tumour invasion.
    Stylli SS; Kaye AH; Lock P
    J Clin Neurosci; 2008 Jul; 15(7):725-37. PubMed ID: 18468901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.